ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,864, issued on Sept. 16, was assigned to Pentixapharm AG (Wurzburg, Germany).
"Humanized antibodies against Lewis Y" was invented by Antje Danielczyk (Berlin), Johanna Gellert (Berlin), Anke Flechner (Berlin) and Patrik Kehler (Berlin).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to humanized anti-Lewis Y antibodies which specifically bind to Lewis Y and do not show any cross-reactivity. Especially, the humanized anti-Lewis Y antibodies do not bind to Lewis b or any other blood group carbohydrate antigen. In particular, the present invention is directed to humanized anti-Lewis Y antibodies which are useful in the tre...